Patents by Inventor Paul Glue

Paul Glue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of neurokinin antagonists in the treatment of urinary incontinence
    Publication number: 20070149504
    Abstract: This invention relates to compounds of formula I, wherein the R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, and, in particular, their use as pharmaceuticals, e.g. use in urinary incontinence.
    Type: Application
    Filed: October 26, 2004
    Publication date: June 28, 2007
    Applicant: NOVARTIS AG
    Inventors: Paul Glue, Kevin McAllister, Eckhard Weber
  • Combination of dopamine agonists and aralkyl and aralkylidene heterocyclic lactams and imides
    Publication number: 20060052373
    Abstract: The present invention relates to a pharmaceutical composition containing (i) a dopamine agonist or a pharmaceutically acceptable salt thereof, (ii) a compound of the formula I as defined in the specification, and optionally (iii) a pharmaceutically acceptable carrier, and to their medicinal use. These compositions are useful as psychotherapeutic agents.
    Type: Application
    Filed: November 17, 2004
    Publication date: March 9, 2006
    Inventors: Paul Glue, Gerard Marek, Mario Saltarelli
  • Organic compounds
    Publication number: 20060046979
    Abstract: Disclosed are pharmaceutical combinations comprising at least one S1P receptor agonist, as well as a method for treating demyelinating diseases, e.g. multiple sclerosis or disorders associated therewith or Guillain-Barré syndrome, comprising co-administration, e.g. concomitantly or in sequence, of a therapeutically effective amount of a) an S1P receptor agonist, and b) at least one co-agent shown to have clinical activity against at least one symptom of a demyelinating disease.
    Type: Application
    Filed: September 23, 2003
    Publication date: March 2, 2006
    Inventors: Carolyn Foster, Peter Hiestand, Paul Glue
  • Combination of dopamine agonists and monoamine reuptake inhibitors
    Publication number: 20050250803
    Abstract: This invention is directed to pharmaceutical compositions and kits comprising (i) a dopamine agonist of the formula II as described in the specification, (ii) a monoamine reuptake inhibitor or pharmaceutically acceptable salt thereof; and optionally (iii) a pharmaceutically acceptable carrier. This invention further relates to methods of treatment using those pharmaceutical compositions.
    Type: Application
    Filed: November 17, 2004
    Publication date: November 10, 2005
    Inventors: Paul Glue, Mario Saltarelli, Gerard Marek
  • Polyethylene glycol modified interferon therapy
    Patent number: 6524570
    Abstract: A method comprising administering a PEG12000-IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: February 25, 2003
    Assignee: Schering Corporation
    Inventors: Paul Glue, David L. Cutler, Melton B. Affrime
  • Polyethylene glycol modified interferon therapy
    Patent number: 6177074
    Abstract: A method comprising administering a PEG12000-IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: January 23, 2001
    Assignee: Schering Corporation
    Inventors: Paul Glue, David L. Cutler, Melton B. Affrime
  • Polyethylene glycol modified interferon therapy
    Patent number: 5908621
    Abstract: A method comprising administering a PEG.sub.12000 -IFN alpha conjugate to an individual afflicted with a viral infection susceptible of treatment with interferon alpha, preferably chronic hepatitis C, is disclosed.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: June 1, 1999
    Assignee: Schering Corporation
    Inventors: Paul Glue, David L. Cutler, Melton B. Affrime